FILTER
LATEST ARTICLES
OEMs and Operators
March 22, 2017
OEMs and operators have a crucial role to play in Ontario’s future growth, since their influence contributes to shaping market trends and resources to develop the aerospace sector’s capabilities in the region through capital investments.
Paying the Price: U.S. Biopharma Industry
March 17, 2017
Slashing drug prices might benefit patients in the short term, but at what cost?
Peru's Mining Sector: Rethinking the Future
March 01, 2017
As the industry becomes more dynamic globally, new strategies are required to avoid fresh growing pains
Expanding Infrastructure, Expanding Horizons
March 01, 2017
Exploration projects in British Columbia continue to take off, as juniors and investors acknowledge the strengths and competitive advantages that operating in this province entails.
The implementation of Industry 4.0 and New Technologies
March 01, 2017
With a limited pool of labor and rising costs, Singapore seeks to develop disruptive manufacturing technologies in order to retain its competitive edge.
Pooling Its Force: U.S. Biopharmaceutical Industry Channels R&D Focus Amid Changing Tides
March 01, 2017
In a time of uncertainty across the board, the United States is still "going boldly” ahead, bringing us innovation and constantly adapting its business model.
Ontario’s Aerospace R&D Ecosystem
February 08, 2017
Ontario must upgrade its established advanced manufacturing industry, embrace disruptive technologies and promote innovation.
Internationalisation: The Road to Success for Italy’s SMEs
February 06, 2017
Italian aerospace companies are generally small and must banned together if they are to be considered for large scale contracts.
Quebéc Aerospace: Education
February 06, 2017
Québec owes a great part of its success in the aerospace industry to the quality of education and training that the province can offer.
Gold, Silver & Copper Mining in Argentina
February 03, 2017
Argentina has seen production of precious metals fall as old mines become depleted and investors wait for expected political reforms to be implemented.
MACIG
SPANISH
SUBSCRIBE TO OUR NEWSLETTER
RECENTLY PUBLISHED
United States Life Sciences 2023
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
In many ways, 2022 was a turning point for the US life sciences industry. After having provided a lightning-quick response to the Covid-19 pandemic, the industry gathered the lessons learned and sought a sense of normalcy to continue developing necessary drugs for patients worldwide. Yet, the geopolitical, macroeconomic, and regulatory environments all come with their set of challenges, forcing executives into increasingly complex decisions when defining their strategies.
PARTNER EVENTS
SUBSCRIBE TO OUR
NEWSLETTER
- Get GBR content delivered to your inbox
- Receive industry based news
- Completely free, e-mail only
